Amgen Europe B.v. competitive analysis

Explore patent oppositions filed by Amgen Europe B.v. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MABJul 26, 2023
Liquid Pharmaceutical CompositionARES TRADINGDec 20, 2018

Latest PTAB cases involving Amgen Europe B.v.

Discover the latest PTAB cases involving Amgen Europe B.v., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Amgen Europe B.v. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMGEN EUROPE B.V.2 - - -
ARES TRADING513 - 1
FRESENIUS KABI DEUTSCHLAND13019 - -
OSSIFI MAB - 6 - -